869 Venetoclax, a specific BCL-2 inhibitor, modulates CAR T cells genetically and functionally during production and augments their anti-tumor response
oleh: Jun Huang, James LaBelle, Ryan Park, Nada S Aboelella, Tony Pan, Erting Tang
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.